Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Does lipitor have side effects on lip flexibility?Does aspirin affect vascepa's cholesterol lowering ability?What excipients are present in apotex's ruxolitinib formulation?Does lipitor affect joint supplement absorption?Can lipitor medication hinder my stretching flexibility?
See the DrugPatentWatch profile for crestor
Patent Exclusivity and Generic Competition Crestor, a popular cholesterol-lowering medication, has seen its patent expire in various countries, paving the way for generic competition. In the United States, the patent for Crestor ( rosuvastatin calcium) expired on October 21, 2020 [1]. This marks the beginning of the end of AstraZeneca's exclusive marketing rights for the brand-name medication. Generic Entry and Pricing As generic versions of Crestor become available, prices are expected to decrease, making the medication more accessible to patients. In the United States, several generic manufacturers have received FDA approval to market their versions of rosuvastatin calcium, including Teva Pharmaceuticals, Mylan, and Alembic Pharmaceuticals [2]. The introduction of generic competition will likely lead to significant price reductions. Discounts and Patient Savings Programs While generic competition will provide cost savings, companies may still offer discounts and patient savings programs for Crestor. AstraZeneca, the manufacturer of the brand-name medication, has a patient assistance program, which provides discounted or free medication to eligible patients [3]. Additionally, pharmacies and pharmacy benefit managers may offer discounts or price-matching programs for Crestor. Important Note Patients should consult their healthcare provider or pharmacist to determine the best option for their specific needs. They may also want to check with their insurance provider or other resources to understand any coverage or discount options available. Sources: [1] DrugPatentWatch.com. (2020). Crestor (rosuvastatin calcium) Drug Patents. Retrieved from https://www.drugpatentwatch.com/drug/crestor-rosuvastatin-calcium [2] FDA. (2020). Rosuvastatin Calcium. Retrieved from https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm [3] AstraZeneca. (2022). Patient Assistance Programs. Retrieved from https://www.astrazeneca-us.com/patient-assistance-programs Citations: 1. DrugPatentWatch.com 2. FDA 3. AstraZeneca
Other Questions About Crestor :